Redsense Medical AB (REDS) - Total Assets
Based on the latest financial reports, Redsense Medical AB (REDS) holds total assets worth Skr39.81 Million SEK (≈ $4.28 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check cash flow reinvestment rate of Redsense Medical AB to assess the company's total reinvestment commitment from operating cash flow.
Redsense Medical AB - Total Assets Trend (2020–2024)
This chart illustrates how Redsense Medical AB's total assets have evolved over time, based on quarterly financial data. Check REDS cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Redsense Medical AB - Asset Composition Analysis
Current Asset Composition (December 2024)
Redsense Medical AB's total assets of Skr39.81 Million consist of 67.0% current assets and 33.0% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 36.7% |
| Accounts Receivable | Skr6.10 Million | 14.6% |
| Inventory | Skr4.02 Million | 9.6% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr13.50 Million | 32.3% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how Redsense Medical AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Redsense Medical AB (REDS) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Redsense Medical AB's current assets represent 67.0% of total assets in 2024, a decrease from 89.9% in 2020.
- Cash Position: Cash and equivalents constituted 36.7% of total assets in 2024, down from 36.9% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 32.0% of total assets, an increase from 7.0% in 2020.
- Asset Diversification: The largest asset category is intangible assets at 32.3% of total assets.
Redsense Medical AB Competitors by Total Assets
Key competitors of Redsense Medical AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
|
Medacta Group SA
SW:MOVE
|
Switzerland | CHF860.76 Million |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Xiangyu Medical Co. Ltd. A
SHG:688626
|
China | CN¥3.27 Billion |
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.17 Billion |
Redsense Medical AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.45 | 5.35 | 4.49 |
| Quick Ratio | 4.69 | 4.28 | 4.23 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr21.21 Million | Skr21.20 Million | Skr14.88 Million |
Redsense Medical AB - Advanced Valuation Insights
This section examines the relationship between Redsense Medical AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.97 |
| Latest Market Cap to Assets Ratio | 0.19 |
| Asset Growth Rate (YoY) | 57.7% |
| Total Assets | Skr41.80 Million |
| Market Capitalization | $7.84 Million USD |
Valuation Analysis
Below Book Valuation: The market values Redsense Medical AB's assets below their book value (0.19x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Redsense Medical AB's assets grew by 57.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Redsense Medical AB (2020–2024)
The table below shows the annual total assets of Redsense Medical AB from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Skr41.80 Million ≈ $4.50 Million |
+57.69% |
| 2023-12-31 | Skr26.50 Million ≈ $2.85 Million |
-13.75% |
| 2022-12-31 | Skr30.73 Million ≈ $3.31 Million |
-28.95% |
| 2021-12-31 | Skr43.25 Million ≈ $4.65 Million |
-45.05% |
| 2020-12-31 | Skr78.70 Million ≈ $8.47 Million |
-- |
About Redsense Medical AB
Redsense Medical AB (publ) develops a monitoring system to detect sign of a blood leak using patented fiber optic technology primarily in Europe, Canada, and the United States. The company offers Redsense System, a product that is used for monitoring and alarming in the case of blood leakage during hemodialysis treatment; and Redsense venous sensor patch, a noninvasive patch that consists of an o… Read more